On Monday 20th of May 2024, the WHO approved 33 national and regional regulatory authorities, including the U.S. FDA and the European Medicines Regulatory Network (EMRN), as WHO Listed Authorities (WLAs), bringing the total to 36 WLAs from 34 Member States since March 2022. This milestone enhances global cooperation and regulatory standards for medicine and vaccine safety and efficacy, with WHO Director-General Dr. Tedros Adhanom Ghebreyesus emphasizing the collective progress in ensuring access to quality healthcare for millions worldwide.
Search this website
All topics
- Access to medicines (43)
- Alerts and recalls (7)
- Audits & Inspections (2)
- BPF (1)
- BPSD (2)
- ENABEL (6)
- Falsified and sub-standard medicines (10)
- GSDP (2)
- International (10)
- ITM (1)
- Latin America (1)
- Literature updates (32)
- MQAS (11)
- National regulatory authority (3)
- News (33)
- PAHO (2)
- Podcast (2)
- QA standards (13)
- QCP (11)
- Quality assurance (33)
- Quamed News (253)
- Recruitment (9)
- Research (7)
- Technical visits (2)
- Training (8)
- USAID (5)
- Webinaire (1)
- Webinar (23)
- WHO (28)
